OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Activation of YAP1 by N6-Methyladenosine–Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma
Yunhao Chen, Zhenan Ling, Xianlei Cai, et al.
Cancer Research (2021) Vol. 82, Iss. 4, pp. 599-614
Open Access | Times Cited: 80
Yunhao Chen, Zhenan Ling, Xianlei Cai, et al.
Cancer Research (2021) Vol. 82, Iss. 4, pp. 599-614
Open Access | Times Cited: 80
Showing 1-25 of 80 citing articles:
Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer
Xueqi Ou, Yeru Tan, Jindong Xie, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101063-101063
Open Access | Times Cited: 67
Xueqi Ou, Yeru Tan, Jindong Xie, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101063-101063
Open Access | Times Cited: 67
ALKBH5-mediated m6A modification of circCCDC134 facilitates cervical cancer metastasis by enhancing HIF1A transcription
Leilei Liang, Yunshu Zhu, Jian Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 59
Leilei Liang, Yunshu Zhu, Jian Li, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 59
Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway
Zhipeng Xu, Shuqiu Chen, Ruiji Liu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 43
Zhipeng Xu, Shuqiu Chen, Ruiji Liu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 43
The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 27
Ziying Liu, Lei Gao, Long Cheng, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 3, pp. 487-501
Open Access | Times Cited: 27
ALKBH5/YTHDF2‐mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation
Yingjie Shao, Zhenhua Liu, Xing Song, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 7
Open Access | Times Cited: 24
Yingjie Shao, Zhenhua Liu, Xing Song, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 7
Open Access | Times Cited: 24
Xiaoyu Ji, Chengzhou Lv, Jiapeng Huang, et al.
Cancer Science (2023) Vol. 114, Iss. 6, pp. 2318-2334
Open Access | Times Cited: 20
N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128–3p/MAPK1 axis
Jiahe Yi, Xueyou Ma, Yufan Ying, et al.
Cancer Letters (2024) Vol. 585, pp. 216613-216613
Open Access | Times Cited: 9
Jiahe Yi, Xueyou Ma, Yufan Ying, et al.
Cancer Letters (2024) Vol. 585, pp. 216613-216613
Open Access | Times Cited: 9
RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 7
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 7
CircMFN2/miR-361-3p/ELK1 feedback loop promotes glutaminolysis and the progression of hepatocellular carcinoma
Xiaopei Hao, Xiangjun Qian, Chenxi Xie, et al.
Cancer Letters (2025), pp. 217473-217473
Closed Access
Xiaopei Hao, Xiangjun Qian, Chenxi Xie, et al.
Cancer Letters (2025), pp. 217473-217473
Closed Access
N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis
Baoxiang Chen, Yuntian Hong, Rui Gui, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 30
Baoxiang Chen, Yuntian Hong, Rui Gui, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 30
Zhaotong Wang, Jiawang Zhou, Haisheng Zhang, et al.
Molecular Oncology (2022) Vol. 17, Iss. 2, pp. 195-229
Open Access | Times Cited: 27
Epigenetic regulation and therapeutic targets in the tumor microenvironment
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 18
Zhuojun Xie, Zirui Zhou, Shuxian Yang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 18
N6-methyladenosine-modified circIRF2, identified by YTHDF2, suppresses liver fibrosis via facilitating FOXO3 nuclear translocation
Xin Chen, Sai Zhu, Hai-Di Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 248, pp. 125811-125811
Closed Access | Times Cited: 15
Xin Chen, Sai Zhu, Hai-Di Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 248, pp. 125811-125811
Closed Access | Times Cited: 15
N6‐methyladenosine‐modified circSTX6 promotes hepatocellular carcinoma progression by regulating the HNRNPD/ATF3 axis and encoding a 144 amino acid polypeptide
Jiahua Lu, Junnan Ru, Yunhao Chen, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 15
Jiahua Lu, Junnan Ru, Yunhao Chen, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 10
Open Access | Times Cited: 15
Effects of RNA methylation on Tumor angiogenesis and cancer progression
Mingyu Han, Haifeng Sun, Quanbo Zhou, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Mingyu Han, Haifeng Sun, Quanbo Zhou, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 14
CircZCCHC2 decreases pirarubicin sensitivity and promotes triple-negative breast cancer development via the miR-1200/TPR axis
Fan Zhang, Dexian Wei, Shishun Xie, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109057-109057
Open Access | Times Cited: 5
Fan Zhang, Dexian Wei, Shishun Xie, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109057-109057
Open Access | Times Cited: 5
Crosstalk between m6A modification and non-coding RNAs in HCC
Zitong Qiu, Xingxing Yuan, Xinyue Wang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111076-111076
Closed Access | Times Cited: 5
Zitong Qiu, Xingxing Yuan, Xinyue Wang, et al.
Cellular Signalling (2024) Vol. 117, pp. 111076-111076
Closed Access | Times Cited: 5
circRNF13, a novel N6-methyladenosine-modified circular RNA, enhances radioresistance in cervical cancer by increasing CXCL1 mRNA stability
Junyu Shi, Xiaohui Rui, Chunxiao Han, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Junyu Shi, Xiaohui Rui, Chunxiao Han, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment
Lan Yang, Siyuan Tian, Xiaohong Zheng, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 8, pp. 718-733
Closed Access | Times Cited: 12
Lan Yang, Siyuan Tian, Xiaohong Zheng, et al.
Journal of Gastroenterology (2023) Vol. 58, Iss. 8, pp. 718-733
Closed Access | Times Cited: 12
Involvement of CircRNAs in regulating The “New Generation of Cancer Hallmarks”: A Special Depiction on Hepatocellular Carcinoma
Alyaa Dawoud, Ramez Elmasri, A.H. Mohamed, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104312-104312
Closed Access | Times Cited: 3
Alyaa Dawoud, Ramez Elmasri, A.H. Mohamed, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104312-104312
Closed Access | Times Cited: 3
RNA modifications in the progression of liver diseases: from fatty liver to cancer
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2105-2119
Open Access | Times Cited: 3
Simiao Li‐Sauerwine, Wajahat Z. Mehal, Xinshou Ouyang
Science China Life Sciences (2024) Vol. 67, Iss. 10, pp. 2105-2119
Open Access | Times Cited: 3
Cross-Talk of Multiple Types of RNA Modification Regulators Uncovers the Tumor Microenvironment and Immune Infiltrates in Soft Tissue Sarcoma
Lin Qi, Wenchao Zhang, Xiaolei Ren, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Lin Qi, Wenchao Zhang, Xiaolei Ren, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
The role of RNA modification in hepatocellular carcinoma
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Qiang Feng, Dongxu Wang, Tianyi Xue, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
The interplay between noncoding RNA and YAP/TAZ signaling in cancers: molecular functions and mechanisms
Yirao Zhang, Yang Wang, Hao Ji, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 16
Yirao Zhang, Yang Wang, Hao Ji, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 16
Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics
Maxime Janin, Verónica Dávalos, Manel Esteller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1071-1112
Open Access | Times Cited: 9
Maxime Janin, Verónica Dávalos, Manel Esteller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1071-1112
Open Access | Times Cited: 9
